How should functionally equivalent drugs be reimbursed?: A retrospective analysis of reimbursement for epoetin alfa and Darbepoetin alfa in 2001–3 and the cost implications for CMS

Kanavos, Panos and Saka, O (2005) How should functionally equivalent drugs be reimbursed?: A retrospective analysis of reimbursement for epoetin alfa and Darbepoetin alfa in 2001–3 and the cost implications for CMS. Disease Management and Health Outcomes, 13 (6). pp. 359-370. ISSN 1173-8790

Full text not available from this repository.

Item Type:	Article
Official URL:	http://diseasemanagement.adisonline.com/
Additional Information:	© 2005 Adis International Ltd
Library of Congress subject classification:	H Social Sciences > H Social Sciences (General)
Sets:	Research centres and groups > LSE Health
Date Deposited:	22 Jul 2008 13:41
URL:	http://eprints.lse.ac.uk/19513/

Actions (login required)

Record administration - authorised staff only